Get startedLog in
    Picture of ExpreS2ion Biotech Holding AB logo

    EXPRS2 — ExpreS2ion Biotech Holding AB News Story

    0.000.00%
    se flag iconLast trade - 00:00
    HealthcareHighly SpeculativeMicro CapSucker Stock
    All News

    Brief: Expres2ion Gets Horizon Europe Grant Of EUR 8 Mln For Vaccine Development

    Picture of ExpreS2ion Biotech Holding AB logoExpreS2ion Biotech Holding AB
    01/12/2023 07:53
    Dec 1 (Reuters) - ExpreS2ion Biotech Holding AB
 EXPRS2.ST :
    * ANNOUNCES NEW EU-FUNDED HORIZON EUROPE GRANT AWARD FOR
NIPAH
VIRUS VACCINE DEVELOPMENT
    * AWARD OF A HORIZON EUROPE GRANT AMOUNTING TO 8 MILLION
EUR,
ABOUT 90 MILLION SEK, TO VICI-DISEASE CONSORTIUM
    * AIM IS TO OBTAIN CLINICAL PROOF-OF-CONCEPT OF A NIPAH
VIRUS
(NIV) VACCINE CANDIDATE WITHIN FOUR YEARS

Source text for Eikon:  ID:nWkrbqPdn3 
Further company coverage:  EXPRS2.ST 

 (Gdansk Newsroom)
 ((gdansk.newsroom@thomsonreuters.com; +48 58 7696600;))

    Recent news on ExpreS2ion Biotech Holding AB

    See all news